Table 2.
Study | 1 Eligibility | 2 Randomized | 3 Concealed | 4 Baseline | 5 Blinding subjects | 6 Blinding therapists | 7 Blinding assessors | 8 Outcomes >85% | 9 Intention to treat analysis | 10 Between group comparisons | 11 Measures of variability | Score |
Hopkins et al
13
2002 |
1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
Rice et al
14
2009 |
1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
Hart et al
15
2014 |
1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 7 |
Kuenze et al
16
2017 |
1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 5 |
Lowe and Dong26
2017 |
1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 5 |
Hart et al
21
2014 |
1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 7 |
Lepley et al
17
2015 |
1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 5 |
Lepley et al
18
2015 |
1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 5 |
Glaviano et al
27
2014 |
1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 9 |
Son et al
19
2016 |
1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 9 |
Konishi et al
20
2017 |
1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
Pamukoff et al
22
2016 |
1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 7 |
Blackburn et al
23
2014 |
1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 6 |
Norte et al
24
2015 |
1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 9 |
Gibbons et al
28
2010 |
1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 8 |
Kim et al
29
2017 |
1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 7 |
Oliveira et al
30
2016 |
1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
Davis et al
31
2011 |
1 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 6 |
Drover et al
32
2004 |
1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 3 |
Ageberg et al
33
2012 |
1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 |
Warner et al
34
2013 |
1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 8 |